GRISELDA ESCAJEDA: Open Payments
NPI 1902389307 · EDINBURG, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$698 in 22 payments from 8 companies in 2025. Trend: 2023 $848 · 2024 $1,126 · 2025 $698
Food & beverage: $588Education: $110
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 2 | $198 |
| Sumitomo Pharma America, Inc. | 11 | $195 |
| Janssen Biotech, Inc. | 2 | $87 |
| COLOPLAST CORP | 1 | $76 |
| Medtronic, Inc. | 1 | $51 |
| Ferring Pharmaceuticals Inc. | 2 | $42 |
| UROGEN PHARMA, INC. | 2 | $33 |
| Endo USA, Inc. | 1 | $16 |
Products named: GEMTESA, Xtandi, Altis, RYBREVANT, INTERSTIM, ADSTILADRIN, JELMYTO, ERLEADA.
Industry payments across TX — which companies pay providers there.
